tiprankstipranks
MicroPort Scientific Corp. (MCRPF)
OTHER OTC:MCRPF

MicroPort Scientific (MCRPF) Stock Price & Analysis

8 Followers

MCRPF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.65 - $2.16
Previous Close$0.91
Volume2.00K
Average Volume (3M)11.96K
Market Cap
$1.66B
Enterprise Value$2.21B
Total Cash (Recent Filing)$1.38B
Total Debt (Recent Filing)$1.29B
Price to Earnings (P/E)-3.5
Beta0.76
Aug 29, 2024
EPS EstimateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.26
Shares Outstanding1,834,477,414
10 Day Avg. Volume200
30 Day Avg. Volume11,955
Standard Deviation0.21
R-Squared0.00031
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.49
Enterprise Value/EbitdaN/A
Forecast
Price Target Upside5.38% Upside
Rating ConsensusHold
Number of Analyst Covering3

Bulls Say, Bears Say

Bulls Say
Financial RecoveryAnticipated recovery with a significant narrowing of net loss, coupled with potential for share price appreciation due to key business catalysts.
Innovation And R&DMicroPort's commitment to innovation is evident through increased R&D investment, boosting its competitiveness on a global scale.
Market LeadershipLeader in China's drugs eluting stents industry with a dominant market share, expanding into new medical device categories.
Bears Say
Company PerformanceR&D expenses cut by 38%, likely to delay product development and reduce future sales growth potential.
Market SentimentShare price has dropped due to a corruption crackdown affecting sales channels.
Regulatory RisksUncertainty of exports to the EU due to potential restrictions on bidding in EU public hospital tenders, as EU counters China’s domestic substitution practices.
---

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%1.73%2.00%96.27%
0.00%
Insiders
2.00% Other Institutional Investors
96.27% Public Companies and
Individual Investors

MCRPF FAQ

What was MicroPort Scientific Corp.’s price range in the past 12 months?
MicroPort Scientific Corp. lowest stock price was $0.65 and its highest was $2.16 in the past 12 months.
    What is MicroPort Scientific Corp.’s market cap?
    Currently, no data Available
    When is MicroPort Scientific Corp.’s upcoming earnings report date?
    MicroPort Scientific Corp.’s upcoming earnings report date is Aug 29, 2024 which is in 102 days.
      How were MicroPort Scientific Corp.’s earnings last quarter?
      MicroPort Scientific Corp. released its earnings results on Mar 28, 2024. The company reported -$0.172 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.172.
        Is MicroPort Scientific Corp. overvalued?
        According to Wall Street analysts MicroPort Scientific Corp.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does MicroPort Scientific Corp. pay dividends?
          MicroPort Scientific Corp. pays a Annually dividend of <$0.01 which represents an annual dividend yield of N/A. See more information on MicroPort Scientific Corp. dividends here
            What is MicroPort Scientific Corp.’s EPS estimate?
            MicroPort Scientific Corp.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does MicroPort Scientific Corp. have?
            MicroPort Scientific Corp. has 1,834,807,400 shares outstanding.
              What happened to MicroPort Scientific Corp.’s price movement after its last earnings report?
              MicroPort Scientific Corp. reported an EPS of -$0.172 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.235%.
                Which hedge fund is a major shareholder of MicroPort Scientific Corp.?
                Currently, no hedge funds are holding shares in MCRPF
                ---

                MicroPort Scientific Stock Smart Score

                2
                Underperform
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -52.98%
                12-Months-Change

                Fundamentals

                Return on Equity
                -50.47%
                Trailing 12-Months
                Asset Growth
                -1.54%
                Trailing 12-Months

                Company Description

                MicroPort Scientific Corp.

                MicroPort Scientific Corp. is an investment holding company, which engages in the research and development, manufacture and distribution of medical devices. It operates through the following segments: Orthopedics Devices Business; Cardiovascular Devices Business; Endovascular Devices Business; Electrophysiology Devices Business; Neurovascular Devices Business; Surgical Management Business; and Diabetes Care and Endocrinal Business. The company was founded by Zhaohua Chang in 1998 and is headquartered in Shanghai, China.
                ---

                MCRPF Stock 12 Month Forecast

                Average Price Target

                $0.98
                ▲(5.38% Upside)
                {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"plus_tr_sans","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4":"$4","-1":"-$1","0.25":"$0.25","1.5":"$1.5","2.75":"$2.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1.15350543,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$1.15</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.98,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$0.98</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.8600023817,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$0.86</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,0.25,1.5,2.75,4],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2023","6":"Sep<br/>2023","9":"Dec<br/>2023","12":"May<br/>2024","25":"May<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.86,0.8825773407692308,0.9051546815384616,0.9277320223076924,0.950309363076923,0.9728867038461538,0.9954640446153846,1.0180413853846155,1.0406187261538462,1.0631960669230769,1.0857734076923078,1.1083507484615385,1.1309280892307694,{"y":1.15350543,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.86,0.8692307692307693,0.8784615384615384,0.8876923076923077,0.8969230769230769,0.9061538461538461,0.9153846153846154,0.9246153846153846,0.9338461538461538,0.943076923076923,0.9523076923076923,0.9615384615384615,0.9707692307692307,{"y":0.98,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.86,0.8600001832076923,0.8600003664153846,0.8600005496230769,0.8600007328307692,0.8600009160384615,0.8600010992461539,0.8600012824538461,0.8600014656615385,0.8600016488692308,0.860001832076923,0.8600020152846154,0.8600021984923076,{"y":0.8600023817,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.43,"date":1675209600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2.88,"date":1677628800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2.36,"date":1680307200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2.2,"date":1682899200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.92,"date":1684454400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.84,"date":1691107200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.72,"date":1693526400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.4,"date":1696550400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.64,"date":1698969600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.58,"date":1701388800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.86,"date":1709856000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.86,"date":1712275200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.86,"date":1714694400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                Similar Stocks
                Company
                Price & Change
                Follow
                Stryker
                Abbott Laboratories
                Becton Dickinson
                Haemonetics
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis